Nuzenio

Ligand Pharmaceuticals Inc

Ligand Pharmaceuticals Inc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 11 publisher sources 100/100 entity strength

Latest news

A Quick Look at Today's Ratings for Ligand Pharmaceuticals(LGND.US), With a Forecast Between $326 to $370 - MoomooMoomoo · Sat, 08 Aug 2026 19:56:43 GMTLigand Pharmaceuticals Incorpor (LGND) Stock Forecasts - Yahoo! Finance CanadaYahoo! Finance Canada · Sat, 08 Aug 2026 14:49:29 GMTLGND SWOT Analysis: Strong Revenue Growth Amidst Valuation Concerns Revealed in 10-Q Filing - GuruFocusGuruFocus · Sat, 08 Aug 2026 06:06:18 GMTLigand Pharmaceuticals Incorporated (LGND) stock price, news, quote and history - Yahoo Finance AustraliaYahoo Finance Australia · Fri, 07 Aug 2026 22:24:14 GMTLigand Pharmaceuticals (LGND) Releases Q2 2026 Earnings: Revenue Declines but EPS Jumps - Quiver QuantitativeQuiver Quantitative · Fri, 07 Aug 2026 20:39:00 GMTLGND Maintained by RBC Capital -- Price Target Raised to $345 - GuruFocusGuruFocus · Fri, 07 Aug 2026 20:24:12 GMTLigand Pharmaceuticals 2Q 2026: Revenue $63.69M, EPS $2.22— 10-Q Summary - TradingViewTradingView · Fri, 07 Aug 2026 20:11:01 GMTLigand Pharmaceuticals, Inc. : H.c. Wainwrigh - MoomooMoomoo · Fri, 07 Aug 2026 12:48:53 GMT

Timeline

Sat, 08 Aug 2026 19:56:43 GMTA Quick Look at Today's Ratings for Ligand Pharmaceuticals(LGND.US), With a Forecast Between $326 to $370 - Moomoo
Sat, 08 Aug 2026 14:49:29 GMTLigand Pharmaceuticals Incorpor (LGND) Stock Forecasts - Yahoo! Finance Canada
Sat, 08 Aug 2026 06:06:18 GMTLGND SWOT Analysis: Strong Revenue Growth Amidst Valuation Concerns Revealed in 10-Q Filing - GuruFocus
Fri, 07 Aug 2026 22:24:14 GMTLigand Pharmaceuticals Incorporated (LGND) stock price, news, quote and history - Yahoo Finance Australia
Fri, 07 Aug 2026 20:39:00 GMTLigand Pharmaceuticals (LGND) Releases Q2 2026 Earnings: Revenue Declines but EPS Jumps - Quiver Quantitative
Fri, 07 Aug 2026 20:24:12 GMTLGND Maintained by RBC Capital -- Price Target Raised to $345 - GuruFocus

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ligand Pharmaceuticals Inc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.